DOCTORS IN THE UKRAINE ACCUSE PRESIDENT OF GENOCIDE
PDFPrintE-mail
Saturday, 21 November 2009 20:35
News - Highlighted News
Canada: The Killer H1N1 Vaccine
By Michel Chossudovsky
URL of this article:
www.globalresearch.ca/index.php?context=va&aid=16192 Global Research, November 20, 2009
"It is a serious thing [vaccine] that has the potential to kill"
according to Dr. Neil Rau, an infectious disease expert, in a CTV
interview, but do not worry: "leading experts insist, the benefits of
the H1N1 vaccine vastly outweigh the risks" (Swine Flu Support Center,
emphasis added)
A new development in the H1N1 Vaccine Saga is unfolding in Canada.
Whereas health officials are pushing for an acceleration of the
vaccination program, there is evidence of so-called "unusual adverse
reactions" including three recently recorded deaths directly resulting
from the vaccine.
In the meantime, health authorities have called for the withdrawal of
170,000 (higher risk) doses of the vaccine produced by
GlaxoSmithKline. The initiative, of which the importance is being
downplayed, is said to have come from the manufacturer
GlaxoSmithKline, which expressed concern on higher than normal adverse
reactions to the vaccine.
"Canada's H1N1 flu vaccine manufacturer has asked the provinces to
temporarily discontinue vaccinating Canadians from a lot of vaccine
shipped in October due to a higher risk of adverse reactions, says a
Manitoba health official.
Dr. Joel Kettner, Manitoba's chief public health officer, said
Thursday that GlaxoSmithKline has asked that the October batch be
taken out of circulation because it produced serious and immediate
anaphylactic reactions in one out of 20,000 vaccinations, compared
with one out of 100,000 in other shipments.
"We've been asked by the manufacturer GSK to not use this vaccine
at this time pending further investigation," he said. (Winnipeg Free
Press, 20 November 2009)
The government is involved in a cover-up. The initial headlines stated
"more than 100,000 doses", but then read on, the number is 170,000
doses.
The CTV report admits that "it is a serious thing, it has the
potential to kill".
Too Late to Withdraw the 170,000 Defective Doses
The question is whether the doses can be withdrawn or whether they
have already been used. The first news reports from Manitoba indicate
that:
Of the 63,000 doses shipped [to Manitoba], only 630 remained unused
by the four regional health authorities in Manitoba that received
them. (Ibid)
This report would suggest that the risky GSK vaccine doses have
already been used.
A subsequent report confirms that out of the 63,000 doses, 900 unused
doses of the H1N1 were withdrawn by health authorities "after health
authorities received word other vaccines from the same batch have been
causing higher rates of allergic reactions than expected." (Flu
vaccine batch pulled in Manitoba, Winnipeg Sun, 20 November 2009).
The question is what happened to remaining 62,100 doses of the higher
risk vaccine batch, which were used to vaccinate people in Manitoba?
Has there been a followup regarding those people in Manitoba who
received the higher risk H1N1 vaccine injection.
Manitoba Health authorities casually confirm, in this regard, that
"most of the vaccine Manitoba received from the suspect lot had
already been used by the time the province received the alert on
Wednesday" [November 18, 2009]. (Winnipeg Free Press, 20 November
2009, emphasis added)
Manitoba and Quebec : Three deaths resulting from the H1N1 Vaccine
The news reports have highlighted deaths allegedly resulting from the
H1N1 flu, while obfuscating several recorded deaths resulting directly
from the vaccine. These vaccine related deaths are occurring at the
very outset of the vaccination program,
According to CTV News, 20 November 2009) "The province is currently
investigating two deaths -- both adults who died within seven days of
getting the H1N1 shot" (Family questions if H1N1 shot caused Manitoba
woman's death, November 20, 2009, emphasis added).
Manitoba officials acknowledge 69 "adverse events" after people
received the swine flu shot, including the two deaths. (CBC.ca report,
17 November 2009)
However, unless the families speak out, the authorities will not
provide details. CTV interviewed the family of one of the victims. No
details on the other death in Manitoba are available:
"The family of a 38-year-old Manitoba woman who died five days
after receiving the H1N1 vaccine are looking for answers as to why it
happened.
Soo Lee Wong and her daughter, Angela Truong, both got the H1N1
shot on November 5th.
The family says Wong, who had diabetes, started getting sick a day
after getting vaccinated and died a few days later.
Doctors told the family Wong died of a blood infection. More tests
will be done to see if the vaccine played any role.
Wong's husband, Thoon Truong, is also caring for his seven-year-old
daughter Angela, who has been in the hospital with a fever and
swollen, painful legs.
He wants to know whether the two cases related to the vaccine or to
something else.
The province is currently investigating two deaths -- both adults
who died within seven days of getting the H1N1 shot.
Although it's still early, Manitoba's chief medical officer of
health Dr. Joel Kettner says immunizations were not likely the cause
of the deaths. CTV News | Family questions if H1N1 shot caused
Manitoba woman's death, November 20, 2009)
It should be noted that these two deaths in Manitoba may have been
associated with the injection of the higher risk H1N1 vaccine doses,
which health authorities had called for withdrawal.
Quebec: One Death
An 80-year-old Quebec man was reported dead after taking the H1N1
Swine Flu vaccination. Health officials have dismissed the case,
"stating that it's too soon to link the death and vaccine." Quebec
man dies after taking H1N1 vaccine, Digital Journal, 18 November
2009).
The Quebec health authorities have refused to provide details:
"Quebec's Director of Public Health Protection, Dr. Horacio Arruda,
did not know why the man took the vaccine and that final test results,
which are expected to come in December, will determine whether or not
the man died from the vaccine.
Canada.com reports the man died in the last three weeks but
provincial officials declined to reveal details, citing
confidentiality concerns. Arruda has said that most allergic reactions
occur right away, which is the reason why many patients are asked to
stay in the centers, “We can't say there is a causal association
between the death and the flu shot.”
Nevertheless, Arruda is confident that the death will not
discourage people from taking the vaccine but urged that serious
reactions to the H1N1 shot are rare, “I understand that everyone is
worried.”" (Quebec man dies after taking H1N1 vaccine, Digital
Journal, 18 November 2009)
The statements by senior health officials are notoriously ambiguous:
while they concur that: "there is no evidence the vaccine is
dangerous.", they nonetheless acknowledge the deaths resulting from
the vaccine (Statement of Quebec's Director of Public Health
Protection, Dr. Horacio Arruda, (The Canadian Press: Quebec health
officials investigating possible death from H1N1 vaccine. November 18,
2009).
Please support Global Research
Global Research relies on the financial support of its readers.
Your endorsement is greatly appreciated
Subscribe to the Global Research e-newsletter
Disclaimer: The views expressed in this article are the sole
responsibility of the author and do not necessarily reflect those of
the Centre for Research on Globalization. The contents of this article
are of sole responsibility of the author(s). The Centre for Research
on Globalization will not be responsible or liable for any inaccurate
or incorrect statements contained in this article.
To become a Member of Global Research
The CRG grants permission to cross-post original Global Research
articles on community internet sites as long as the text & title are
not modified. The source and the author's copyright must be displayed.
For publication of Global Research articles in print or other forms
including commercial internet sites, contact: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
www.globalresearch.ca contains copyrighted material the use of which
has not always been specifically authorized by the copyright owner. We
are making such material available to our readers under the provisions
of "fair use" in an effort to advance a better understanding of
political, economic and social issues. The material on this site is
distributed without profit to those who have expressed a prior
interest in receiving it for research and educational purposes. If you
wish to use copyrighted material for purposes other than "fair use"
you must request permission from the copyright owner.
For media inquiries: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
© Copyright Michel Chossudovsky, Global Research, 2009
The url address of this article is:
www.globalresearch.ca/index.php?context=va&aid=16192 © Copyright 2005-2007 GlobalResearch.ca
Web site engine by Polygraphx Multimedia © Copyright 2005-2007
Forward email
http://ui.constantcontact.com/sa/fwtf.j ... 2840230710 Privacy Policy:
http://ui.constantcontact.com/roving/CC ... Policy.jsp Email Marketing by
Constant Contact(R)
www.constantcontact.com GLOBAL RESEARCH | v | Montreal | Canada
Add this page to Social Bookmarking websites
Reddit! Del.icio.us! Mixx! Free and Open Source Software News Google! Live! Facebook! StumbleUpon! TwitThis Joomla Free PHP
Thank you for helping spreading the news!
click to delete